NeueHealth Inc (NYSE:NEUE)

$ 5 -0.24 (-4.58%) Market Cap: 41.42 Mil Enterprise Value: 965.40 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 54/100

Q3 2024 NeueHealth Inc Earnings Call Transcript
Nov 07, 2024

$5.25 (+6.36%)

Earnings
Q2 2024 NeueHealth Inc Earnings Call Transcript
Aug 07, 2024

$5.16 (-3.48%)

Earnings
Q1 2024 NeueHealth Inc Earnings Call Transcript
May 08, 2024

$6.42 (+1.90%)

Earnings
Q4 2023 NeueHealth Inc Earnings Call Transcript
Mar 06, 2024

$10.1 (+18.13%)

Earnings
Q3 2023 Bright Health Group Inc Earnings Call Transcript
Nov 07, 2023

$7.62 (+0.93%)

Earnings
Q2 2023 Bright Health Group Inc Earnings Call Transcript
Aug 09, 2023

$15.41 (-12.34%)

Earnings
Q1 2023 Bright Health Group Inc Earnings Call Transcript
May 09, 2023

$20.8 (+52.94%)

Earnings
Q4 2022 Bright Health Group Inc Earnings Call Transcript
Mar 01, 2023

$40.34 (-42.05%)

Earnings
Bright Health Group Inc at JPMorgan Healthcare Conference Transcript
Jan 11, 2023
Q3 2022 Bright Health Group Inc Earnings Call Transcript
Nov 09, 2022

$71.42 (-8.75%)

Earnings
Bright Health Group, Inc. - Special Call Transcript
Oct 11, 2022
Q2 2022 Bright Health Group Inc Earnings Call Transcript
Aug 10, 2022

$136.8 (-11.86%)

Earnings
Bright Health Group Inc at Bank of America Healthcare Conference Transcript
May 10, 2022
Q1 2022 Bright Health Group Inc Earnings Call Transcript
May 04, 2022

$179.2 (+33.33%)

Earnings
Q4 2021 Bright Health Group Inc Earnings Call Transcript
Mar 02, 2022

$200.8 (-19.55%)

Earnings
Bright Health Group Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 11, 2022
Bright Health Group Inc Corporate Analyst Meeting Transcript
Dec 07, 2021
Q3 2021 Bright Health Group Inc Earnings Call Transcript
Nov 11, 2021

$395.2 (-32.33%)

Earnings
Bright Health Group Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 15, 2021
Q2 2021 Bright Health Group Inc Earnings Call Transcript
Aug 03, 2021

$679.2 (-22.25%)

Earnings

Bright Health Group Inc at JPMorgan Healthcare Conference Transcript

Jan 11, 2023 / 11:00PM GMT

Release Date Price: $63.35 (-2.77%)

Transcript 8-K

Lisa Christine Gill

JPMorgan Chase & Co, Research Division - MD, Head of U.S. Healthcare Technology & Distribution Equity Research and Senior Research Analyst

Good afternoon. My name is Lisa Gill, and I'm the health care services analyst with Morgan. It is with great pleasure this afternoon that we have with us Bright Health Group. Presenting for Bright Health Group is CEO, Mike Mikan. Post Mike's presentation, he will join myself; and CFO, Cathy Smith, over at the table to take questions.

With that, Mike?

George Lawrence Mikan

Bright Health Group, Inc. - Vice Chairman, CEO & President

Great. Thanks, Lisa, for that introduction and JPMorgan for inviting me to speak this afternoon about the incredible work that our team at Bright Health Group has been doing over the past year.

It goes without saying that there has been significant challenges across our sector for the 2021 IPO class and Bright Health Group as a company. As I'll talk about today, despite those challenges, the team has done a tremendous job rallying around our

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.